WIXLIB

Tentative Program9th Euro-Global Summit onToxicology and Applied PharmacologyParis, France June 22-24, 2017Paving the Path forQuality Tox ConnectionsConference Secretariat57 Ullswater Avenue,West End, Southampton, Hampshire, SO18 3QS United KingdomTel: 1-702-508-5197, Ext: 8066Email: gy.global-summit.com/europe/

EEuro Toxicology’s Scientific BoardPhilip WexlerNational Library of Medicine (NLM)USAStefano BONASSIHead, IRCCS San RaffaelePisana, ItalyAnna Radominska PandyaUniversity of Arkansas for MedicalSciences, USAWei ZhengPurdue UniversityUSAInoviem Scientific, FranceJosé Fernando Santos AlmeidaInstituto Universitário da MaiaPortugalEric EzanHealth Technology Program-CEA, FranceMarcelo L. LarramendyBenoît SchoefsUniversity of Le MansFrancePierre EftekhariYazan AkkamYarmouk University, JordanFarhan SahitoINTERPOL, FranceNational University of La PlataArgentinaSwamy K BMahsa University-JalanElmu Off Jalan UniversityMalaysiaMyung-Haing ChoKorean Society of ToxicologyKoreaIzaskun LarrietaUniversity of the BasqueSpain

Stefano BonassiIRCCS San Raffaele Pisana,Rome, ItalyStefano BONASSI, born on January, 3, 1956 is a Doctor in Biological Sciences - University of Genova and a Specialist in Medical Statistics and Epidemiology University of Pavia. He is a Faculty for PhD programs in human genetics of the Universidad Autonoma de Barcelona, Barcelona, Spain, and M2E2 Internationalcourses of Molecular Epidemiology of Chronic diseases at the Maastricht University, the Netherlands . He is a reviewer of many Journals such as ExperimentalResearch; Mutagenesis; Cancer Epidemiology, Biomarkers & Prevention Et al.Philip WexlerNational Library ofMedicine (NLM), USAPhilip Wexler is a Technical Information Specialist at the National Library of Medicine’s (NLM) Toxicology and Environmental Health Information Program(TEHIP) and federal liaison to the Toxicology Education Foundation. He is the Editor-in-Chief of three editions of the Encyclopedia of Toxicology (Elsevier. 3rded. 2014), four editions of Information Resources in Toxicology (Elsevier. 4th ed. 2009), Chemicals, Environment, Health: A Global Management Perspective (CRCPress/Taylor and Francis. 2011), and the Taylor and Francis journal, Global Security: Health, Science, and Policy. He is also overseeing an Elsevier monographicseries on Toxicology History. Two volumes on Toxicology in Antiquity have been published and a follow-up on Toxicology in the Middle Ages and Renaissanceis scheduled for publication in March, 2017. He is a recipient of the NLM Regents Award for Scholarly or Technical Achievement and the US Society ofToxicology’s Public Communications Award.Pierre EftekhariInoviem ScientificFrancePierre Eftekhari has completed his PhD from Strasbourg University. He has more than 19 years of experience in Drug Development and is the President ofInoviem Scientific, a company dedicated to cutting edge solutions in drug development. He has published more than 30 papers in reputed journals and filedseveral patentsEric EzanHealth TechnologyProgram-CEAFranceEric Ezan studied Biological Engineering at the University of Compiegne, France. After a first experience at the University of Waterloo (Ontario), he obtained aPhD degree at the University Paris V in Pharmacological Sciences (1989). He then joined the Institute Pasteur of Paris for two-year Post-doctoral experience.He was recruited by the CEA (Alternative Energies and Atomic Energy Commission) in 1991, where he became the Head of the Laboratory for Drug Metabolismat the CEA in 2000. This laboratory located at Saclay, south of Paris, is involved in the development of immunological methods and mass spectrometry for thediscovery of biomarkers and quantification of small molecular weight drugs and biologicals for preclinical and clinical applications. The laboratory also becamea leader in the use of mass spectrometry approaches for the detection biological weapons. In 2014, he joined the CEA Program for the development of healthtechnology.

José Fernando SantosAlmeidaInstituto Universitário daMaia, PortugalJosé Fernando Santos Almeida is a Psychiatrist and completed his PhD from Instituto de Ciências Biomédicas Abel Salazar (Universidade do Porto). He is aProfessor and President of Scientifi c Council of Instituto Universitário da Maia and Editor-Chief of Psiquiatria, Psicologia & Justiça.Anna RadominskaPandya University of Arkansasfor Medical Sciences, USAAnna Radominska Pandya serves as a Professor in the Department of Biochemistry and Molecular Biology at UAMS; and she is the Editor in Chief for DrugMetabolism Review. She received her PhD from the Institute of Biochemistry and Biophysics, Polish Academy of Sciences in Warsaw, Poland. She has published175 papers in various peer-reviewed journals, and she has received twelve R01 grants from the NIH and DoD. Her research interests include: The regulationand suppression of human UGTs and their role as anti-proliferative agents in cancer models, the interactions between UGTs and cannabinoid receptors, thedelivery of UGT genes and drugs into cancer cells using nanomaterial, and the roles of UGTs in the biotransformation of drugs including resveratrols and drugsof abuse such as marijuana and synthetic cannabinoids.Dr. Zheng received his Ph.D. from University of Arizona in Tucson. He was an assistant professor (1993-2000) and laterassociate professor (2000-2003) at Columbia University in New York city. Dr. Zheng joined Purdue University in 2003 andbecame a full professor in 2006. He has been serving as the Head of School of Sciences since 2008. Dr. Zheng has published one book, 161 peer-reviewedpapers and more than 220 meeting proceedings and abstracts. He is a Fellow of the U.S. Academy of Toxicological Sciences and a frequet reviewer for NIHstudy sections and for more than 40 research journals.Yazan AkkamYarmouk UniversityJordanYazan Akkam has completed his PhD from University of Arkansas and Post-doctoral studies on Nanotoxicity from Institute forNanosciences and Engineering, Arkansas. He is the Head of Department of Pharmaceutical Sciences, Faculty of Pharmacy, Yarmouk University, Jordan. Also, heis a Member of the National Committee for the Management of Nanomaterials- Ministry of Environment, Jordan.

Program at a GlanceDay 108.00-09.00General SessionEvening SessionsMorning SessionsTimeLeast of 3 .15Inaugural AddressKeynote/Plenary Talk 1Keynote/Plenary Talk 210.15-10.45Keynote/Plenary Talk 3Panel Discussions/Group Photo11.00-12.40Coffee/Tea Break 10.45-11.00 (Networking)5 Speakers (20 Mins Each)13.30-15.30Lunch Break 12.40-13.306 Speakers (20 Mins Each)15.45-17.25Coffee/Tea Break 15.30-15.45 (Networking)5 Speakers (20 Mins Each)19 Speakers for Day ession 15 Speakers (20 Mins Each)Coffee/Tea Break 10.40-10.55 (Networking)5 Speakers (20 Mins Each)Session 25 Speakers (20 Mins Each)5 Speakers (20 Mins Each)Lunch Break 12.35-13.2513.25-15.055 Speakers (20 Mins Each)5 Speakers (20 Mins Each)Poster Sessions40 Speakers on Day 2Evening SessionsMorning SessionsDay 2Coffee/Tea Break 15.05-15.20 (Networking)15.20-17.005 Speakers (20 Mins Each)5 Speakers (20 Mins Each)Time09.00-10.4010.55-12.3513.25-15.05Session 15 Speakers (20 Mins Each)Coffee/Tea Break 10.40-10.55 (Networking)5 Speakers (20 Mins Each)Lunch Break 12.35-13.255 Speakers (20 Mins Each)Awards & Closing CeremonySession 25 Speakers (20 Mins Each)5 Speakers (20 Mins Each)5 Speakers (20 Mins Each)30 Speakers on Day 3Evening SessionsMorning SessionsDay 3

FEATURED SPEAKERSTitle: Cannabinoid receptors and their ligands: Role in cancer proliferatioAnna Radominska-Pandya, UAMS, USATitle: Microalgae: a source of food colour additives for a better healthBenoît Schoefs, University of Le Mans, FranceTitle: An Engineered pH Sensitive PCSK9 Antibody to Enhance Pharmcokinetic and PharmacodynamicPropertiesPamela Garzone, Pfizer, Inc. USATitle: Natural nanostructures (lipoproteids of blood plasma) play the important role in the development ofpathological statesLankin V, Russian Cardiology Research Complex, RussiaTitle: Glyphosat and its the most popular product (Roundup) affect the secretion of myometrialcontractions regulators from bovine ovary and uterus in vitroMichał H. Wróbel, Polish Academy of Sciences, PolandTitle: Bisphenol A analogs and new brominated flame retardants: Do their metabolites have endocrineactivity?Lucija Peterlin Mašič, University of Ljubljana, SloveniaTitle: Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in MiceFu-Dong Shi, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, USATitle: Cancer Incidence in Coal Combustion Waste Landfill WorkersJames Dahlgren & Patrick Talbott, CanadaTitle: Fluorescence-based cell assay for high-throughput detection of endocrine-disrupting chemicals (EDCs)in water sources: principle and applicationsDiana A. Stavreva, National Institutes of Health, USAExhibitor Hosted SessionModerated ByRemy Hoffmann, Senior Director Business Development Europe – Discovery Services, FranceTitle: Assessment of toxicogenetic activity of oleoresins of five Copaifera species for prediction of potentialhuman risksDenise C. Tavares, University of Franca, BrazilKeynote Slots Available

Featured SpeakersTitle: Allelopathy of Eucalyptus grandisDanju Zhang, Sichuan Agricultural university, ChinaTitle: Biosynthesized silver nanoparticles: decoding their mechanism of action in S. aureus and E. coli.Quinteros MA, CONICET, ArgentinaTitle: Protective effect of betaine on paraquat-induced oxidative stress and pulmonary injury in ratsYoung C Kim, Seoul National University, KoreaTitle: The differences of apoptosis and pulmonary fibrosis following sulfur mustard-induced acutepulmonary injury via intraperitoneal injection and intratracheal instillation in ratsZhu Xiaoji, The 89th Hospital of PLA, ChinaTitle: Activation of FGF2-FGFR1 axis by visceral fat is responsible for malignant transformation of epithelialcells in mice kept on high fat dietDebrup Chakraborty, Michigan State University, USATitle: Genetic determinants of methotrexate toxicity in Tunisian patients with rheumatoid arthritis: a studyof polymorphisms in key methotrexate pathway genesAbdellatif Maalej, Laboratory of Human Molecular Genetics, Sfax, TunisiaTitle: Influence of 137Cs on the wildlife in the Kopački Rit Nature Park, CroatiaBranko Petrinec, Institute for Medical Research and Occupational Health, CroatiaTitle: Comparative repeated toxicity study in rats: enoxaparin biosimilar product versus reference productKobbi Zina, University of Monastir, TunisiaTitle: Protective Effect of Hydroalcoholic Extract of Portulaca Oleracea against Cadmium InducedNephrotoxicityJavad Babaei, Valiasr Hospital Research CenterSpe a k e r Sl ots A v a i l a b l e